Engineered Nanomaterials: The Challenges and Opportunities for Nanomedicines

Fahad Albalawi,1,2,* Mohd Zobir Hussein,2,* Sharida Fakurazi,3,4 Mas Jaffri Masarudin5 1Department of Medical Laboratory and Blood Bank, King Fahad Specialist Hospital-Tabuk, Tabuk, Saudi Arabia; 2Materials Synthesis and Characterization Laboratory, Institute of Advanced Technology (ITMA), Universit...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Albalawi F, Hussein MZ, Fakurazi S, Masarudin MJ
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2021
Materias:
Acceso en línea:https://doaj.org/article/7d7f9a147aa1441aaac873d296c5ea2d
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:7d7f9a147aa1441aaac873d296c5ea2d
record_format dspace
spelling oai:doaj.org-article:7d7f9a147aa1441aaac873d296c5ea2d2021-12-02T18:12:30ZEngineered Nanomaterials: The Challenges and Opportunities for Nanomedicines1178-2013https://doaj.org/article/7d7f9a147aa1441aaac873d296c5ea2d2021-01-01T00:00:00Zhttps://www.dovepress.com/engineered-nanomaterials-the-challenges-and-opportunities-for-nanomedi-peer-reviewed-article-IJNhttps://doaj.org/toc/1178-2013Fahad Albalawi,1,2,* Mohd Zobir Hussein,2,* Sharida Fakurazi,3,4 Mas Jaffri Masarudin5 1Department of Medical Laboratory and Blood Bank, King Fahad Specialist Hospital-Tabuk, Tabuk, Saudi Arabia; 2Materials Synthesis and Characterization Laboratory, Institute of Advanced Technology (ITMA), Universiti Putra Malaysia, Serdang, Selangor, Malaysia; 3Department of Human Anatomy, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Serdang, Selangor, Malaysia; 4Natural Medicine and Product Research Laboratory Institute of Bioscience, Serdang, Selangor, Malaysia; 5Department of Cell and Molecular Biology, Faculty of Biotechnology and Biomolecular Sciences, Universiti Putra Malaysia, Serdang, Selangor, Malaysia*These authors contributed equally to this workCorrespondence: Mohd Zobir Hussein Email mzobir@upm.edu.myAbstract: The emergence of nanotechnology as a key enabling technology over the past years has opened avenues for new and innovative applications in nanomedicine. From the business aspect, the nanomedicine market was estimated to worth USD 293.1 billion by 2022 with a perception of market growth to USD 350.8 billion in 2025. Despite these opportunities, the underlying challenges for the future of engineered nanomaterials (ENMs) in nanomedicine research became a significant obstacle in bringing ENMs into clinical stages. These challenges include the capability to design bias-free methods in evaluating ENMs’ toxicity due to the lack of suitable detection and inconsistent characterization techniques. Therefore, in this literature review, the state-of-the-art of engineered nanomaterials in nanomedicine, their toxicology issues, the working framework in developing a toxicology benchmark and technical characterization techniques in determining the toxicity of ENMs from the reported literature are explored.Keywords: engineered nanomaterials, nanomedicine, nanotoxicology, particle tracking analysis, asymmetric flow field-flow fractionation, Taylor dispersion analysisAlbalawi FHussein MZFakurazi SMasarudin MJDove Medical Pressarticleengineered nanomaterialsnanomedicinenanotoxicologyparticle tracking analysisasymmetric flow field-flow fractionationtaylor dispersion analysistunable resistive pulse sensing.Medicine (General)R5-920ENInternational Journal of Nanomedicine, Vol Volume 16, Pp 161-184 (2021)
institution DOAJ
collection DOAJ
language EN
topic engineered nanomaterials
nanomedicine
nanotoxicology
particle tracking analysis
asymmetric flow field-flow fractionation
taylor dispersion analysis
tunable resistive pulse sensing.
Medicine (General)
R5-920
spellingShingle engineered nanomaterials
nanomedicine
nanotoxicology
particle tracking analysis
asymmetric flow field-flow fractionation
taylor dispersion analysis
tunable resistive pulse sensing.
Medicine (General)
R5-920
Albalawi F
Hussein MZ
Fakurazi S
Masarudin MJ
Engineered Nanomaterials: The Challenges and Opportunities for Nanomedicines
description Fahad Albalawi,1,2,* Mohd Zobir Hussein,2,* Sharida Fakurazi,3,4 Mas Jaffri Masarudin5 1Department of Medical Laboratory and Blood Bank, King Fahad Specialist Hospital-Tabuk, Tabuk, Saudi Arabia; 2Materials Synthesis and Characterization Laboratory, Institute of Advanced Technology (ITMA), Universiti Putra Malaysia, Serdang, Selangor, Malaysia; 3Department of Human Anatomy, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Serdang, Selangor, Malaysia; 4Natural Medicine and Product Research Laboratory Institute of Bioscience, Serdang, Selangor, Malaysia; 5Department of Cell and Molecular Biology, Faculty of Biotechnology and Biomolecular Sciences, Universiti Putra Malaysia, Serdang, Selangor, Malaysia*These authors contributed equally to this workCorrespondence: Mohd Zobir Hussein Email mzobir@upm.edu.myAbstract: The emergence of nanotechnology as a key enabling technology over the past years has opened avenues for new and innovative applications in nanomedicine. From the business aspect, the nanomedicine market was estimated to worth USD 293.1 billion by 2022 with a perception of market growth to USD 350.8 billion in 2025. Despite these opportunities, the underlying challenges for the future of engineered nanomaterials (ENMs) in nanomedicine research became a significant obstacle in bringing ENMs into clinical stages. These challenges include the capability to design bias-free methods in evaluating ENMs’ toxicity due to the lack of suitable detection and inconsistent characterization techniques. Therefore, in this literature review, the state-of-the-art of engineered nanomaterials in nanomedicine, their toxicology issues, the working framework in developing a toxicology benchmark and technical characterization techniques in determining the toxicity of ENMs from the reported literature are explored.Keywords: engineered nanomaterials, nanomedicine, nanotoxicology, particle tracking analysis, asymmetric flow field-flow fractionation, Taylor dispersion analysis
format article
author Albalawi F
Hussein MZ
Fakurazi S
Masarudin MJ
author_facet Albalawi F
Hussein MZ
Fakurazi S
Masarudin MJ
author_sort Albalawi F
title Engineered Nanomaterials: The Challenges and Opportunities for Nanomedicines
title_short Engineered Nanomaterials: The Challenges and Opportunities for Nanomedicines
title_full Engineered Nanomaterials: The Challenges and Opportunities for Nanomedicines
title_fullStr Engineered Nanomaterials: The Challenges and Opportunities for Nanomedicines
title_full_unstemmed Engineered Nanomaterials: The Challenges and Opportunities for Nanomedicines
title_sort engineered nanomaterials: the challenges and opportunities for nanomedicines
publisher Dove Medical Press
publishDate 2021
url https://doaj.org/article/7d7f9a147aa1441aaac873d296c5ea2d
work_keys_str_mv AT albalawif engineerednanomaterialsthechallengesandopportunitiesfornanomedicines
AT husseinmz engineerednanomaterialsthechallengesandopportunitiesfornanomedicines
AT fakurazis engineerednanomaterialsthechallengesandopportunitiesfornanomedicines
AT masarudinmj engineerednanomaterialsthechallengesandopportunitiesfornanomedicines
_version_ 1718378518629318656